666754-28-5

Upstream product

• 666754-26-3 (-)-N-[(R)-2-hydroxy-1-(tert-butyldimethylsilanyloxymethyl)but-3-enyl]benzamide 

Downstream Products

• 666754-29-6 1(R)-[2-(tert-butyldimethylsiloxy)-1(R)-[[N-(phenylmethoxy)carbonyl]amino]ethyl]prop-2-enyl benzoate 
• 666754-31-0 (2R,3R,4S,6R)-4-benzoxy-6-(tert-butyldimethylsiloxy)-5-[[N-(phenylmethoxy)carbonyl]amino]hexanoic acid methyl ester 2,3,4,6-tetrol 
• 666754-30-9 methyl 4(R)-benzoxy-6-(tert-butyldimethylsiloxy)-5(R)-[[N-(phenylmethoxy)carbonyl]amino]hex-2(E)-enoate 
• 666754-32-1 (3R,4R,5S,6R)-4-benzoxy-6-(tert-butyldimethylsilyloxymethyl)-3,4-dihydroxypiperidin-2-one 

Relevant academic research and scientific papers

Asymmetric synthesis of (-)-swainsonine

(Chemical Equation Presented) We report a new asymmetric synthetic method for (-)-swainsonine utilizing a chiral oxazoline precursor. The key features in this strategy are the diastereoselective oxazoline formation reaction catalyzed by palladium(0), dias

Synthesis of (+)-1-deoxygalactonojirimycin

A total synthesis of (+)-1-deoxygalactonojirimycin has been accomplished using stereoselective dihydroxylation and piperidine formation by catalytic hydrogenation.